INNOVIVA, INC. Increase (Decrease) in Receivables
INNOVIVA, INC. (INVA) reported Increase (Decrease) in Receivables of $1.43 million for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-11-01.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInReceivables · last filed 2013-11-01
- INNOVIVA, INC. increase (decrease) in receivables for the quarter ending 2013-09-30 was $256.00K.
- INNOVIVA, INC. increase (decrease) in receivables for the quarter ending 2013-06-30 was $16.00K, a 48.39% decline year-over-year.
- INNOVIVA, INC. increase (decrease) in receivables for the quarter ending 2013-03-31 was $1.15M.
- INNOVIVA, INC. increase (decrease) in receivables for the quarter ending 2012-12-31 was $993.00K, a 599.30% increase year-over-year.
- INNOVIVA, INC. increase (decrease) in receivables for fiscal 2012 was $841.00K, a 2800.00% increase from fiscal 2011.
- INNOVIVA, INC. increase (decrease) in receivables for fiscal 2011 was $29.00K.
- INNOVIVA, INC. increase (decrease) in receivables for fiscal 2010 was -$81.00K.
- INNOVIVA, INC. increase (decrease) in receivables for fiscal 2009 was -$14.00K.
| Period end | Increase (Decrease) in Receivables 3 month | Increase (Decrease) in Receivables 6 month | Increase (Decrease) in Receivables 9 month | Increase (Decrease) in Receivables 12 month |
|---|---|---|---|---|
| 2013-09-30 | $256.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | $272.00K derived: sum of 2 quarters · filed 2013-11-01 | $1.43M 10-Q · filed 2013-11-01 | $2.42M derived: sum of 4 quarters · filed 2013-11-01 |
| 2013-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $1.17M 10-Q · filed 2013-08-01 | $2.16M derived: sum of 3 quarters · filed 2013-08-01 | $2.14M derived: sum of 4 quarters · filed 2013-11-01 |
| 2013-03-31 | $1.15M 10-Q · filed 2013-05-01 | $2.15M derived: sum of 2 quarters · filed 2013-05-01 | $2.12M derived: sum of 3 quarters · filed 2013-11-01 | $2.15M derived: sum of 4 quarters · filed 2013-11-01 |
| 2012-12-31 | $993.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $970.00K derived: sum of 2 quarters · filed 2013-11-01 | $1.00M derived: sum of 3 quarters · filed 2013-11-01 | $841.00K 10-K · filed 2013-02-26 |
| 2012-09-30 | -$23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | $8.00K derived: sum of 2 quarters · filed 2013-11-01 | -$152.00K 10-Q · filed 2013-11-01 | -$10.00K derived: sum of 4 quarters · filed 2013-11-01 |
| 2012-06-30 | $31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | -$129.00K 10-Q · filed 2013-08-01 | $13.00K derived: sum of 3 quarters · filed 2013-08-01 | -$153.00K derived: sum of 4 quarters · filed 2013-08-01 |
| 2012-03-31 | -$160.00K 10-Q · filed 2013-05-01 | -$18.00K derived: sum of 2 quarters · filed 2013-05-01 | -$184.00K derived: sum of 3 quarters · filed 2013-05-01 | $137.00K derived: sum of 4 quarters · filed 2013-05-01 |
| 2011-12-31 | $142.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | -$24.00K derived: sum of 2 quarters · filed 2013-02-26 | $297.00K derived: sum of 3 quarters · filed 2013-02-26 | $29.00K 10-K · filed 2013-02-26 |
| 2011-09-30 | -$166.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-31 | $155.00K derived: sum of 2 quarters · filed 2012-10-31 | -$113.00K 10-Q · filed 2012-10-31 | -$119.00K derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-06-30 | $321.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-01 | $53.00K 10-Q · filed 2012-08-01 | $47.00K derived: sum of 3 quarters · filed 2013-02-26 | -$187.00K derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-03-31 | -$268.00K 10-Q · filed 2012-05-02 | -$274.00K derived: sum of 2 quarters · filed 2013-02-26 | -$508.00K derived: sum of 3 quarters · filed 2013-02-26 | |
| 2010-12-31 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | -$240.00K derived: sum of 2 quarters · filed 2013-02-26 | -$81.00K 10-K · filed 2013-02-26 | |
| 2010-09-30 | -$234.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-02 | -$75.00K 10-Q · filed 2011-11-02 | ||
| 2010-06-30 | $159.00K 10-Q · filed 2011-08-03 | |||
| 2009-12-31 | -$14.00K 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |